TLR4 and cancer: In conclusion, our work identifies TLR4 as an important pro-tumor activator of MSC phenotype suggesting that upon activation, the stroma is progressively inflammatory-imprinted by PC to an “autonomous” state where it becomes independent from cancer cells because MM-MSC maintain this immune alteration after in vitro expansion.